-
公开(公告)号:NO972707D0
公开(公告)日:1997-06-12
申请号:NO972707
申请日:1997-06-12
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN-LUC , NOTHACKER HANS-PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94
Abstract: The present invention relates to a method of screening for a therapeutically useful compound which comprises testing an LC132 receptor agonist in a screening assay for psychiatric and/or neurological disorders. More particularly, the screening method is based on contacting an LC132 receptor with an agent suspected of being an agonist of the LC132 receptor function, followed by the detection of the binding and/or the agonist activity of the compound and then testing of an agent with LC132 agonist activity in an antiepileptic, anticonvulsant or anxiolytic screening assay.
-
公开(公告)号:HU9701032A2
公开(公告)日:1998-08-28
申请号:HU9701032
申请日:1997-06-11
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN-LUC , NOTHACKER HANS-PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94
Abstract: The present invention relates to a method of screening for a therapeutically useful compound which comprises testing an LC132 receptor agonist in a screening assay for psychiatric and/or neurological disorders. More particularly, the screening method is based on contacting an LC132 receptor with an agent suspected of being an agonist of the LC132 receptor function, followed by the detection of the binding and/or the agonist activity of the compound and then testing of an agent with LC132 agonist activity in an antiepileptic, anticonvulsant or anxiolytic screening assay.
-
公开(公告)号:CZ9701795A3
公开(公告)日:1998-03-18
申请号:CZ179597
申请日:1997-06-11
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN LUC , NOTHACKER HANS PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94
CPC classification number: G01N33/9486 , G01N33/566 , G01N2500/00
-
公开(公告)号:ZA9705077B
公开(公告)日:1997-12-15
申请号:ZA9705077
申请日:1997-06-09
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN-LUC , NOTHACKER HANS-PETER , REINSCHELD RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94 , G01N , A61K
CPC classification number: G01N33/9486 , G01N33/566 , G01N2500/00
-
公开(公告)号:NO972707A
公开(公告)日:1997-12-15
申请号:NO972707
申请日:1997-06-12
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN-LUC , NOTHACKER HANS-PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94 , G01N33/68
CPC classification number: G01N33/9486 , G01N33/566 , G01N2500/00
-
公开(公告)号:AU719519B2
公开(公告)日:2000-05-11
申请号:AU2485397
申请日:1997-06-12
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN-LUC , NOTHACKER HANS-PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94 , G01N33/68
Abstract: The present invention relates to a method of screening for a therapeutically useful compound which comprises testing an LC132 receptor agonist in a screening assay for psychiatric and/or neurological disorders. More particularly, the screening method is based on contacting an LC132 receptor with an agent suspected of being an agonist of the LC132 receptor function, followed by the detection of the binding and/or the agonist activity of the compound and then testing of an agent with LC132 agonist activity in an antiepileptic, anticonvulsant or anxiolytic screening assay.
-
17.
公开(公告)号:NZ328033A
公开(公告)日:1998-11-25
申请号:NZ32803397
申请日:1997-06-06
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN-LUC , NOTHACKER HANS-PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94 , G01N33/68 , C07K14/435
Abstract: The present invention relates to a method of screening for a therapeutically useful compound which comprises testing an LC132 receptor agonist in a screening assay for psychiatric and/or neurological disorders. More particularly, the screening method is based on contacting an LC132 receptor with an agent suspected of being an agonist of the LC132 receptor function, followed by the detection of the binding and/or the agonist activity of the compound and then testing of an agent with LC132 agonist activity in an antiepileptic, anticonvulsant or anxiolytic screening assay.
-
公开(公告)号:CZ179597A3
公开(公告)日:1998-03-18
申请号:CZ179597
申请日:1997-06-11
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN LUC , NOTHACKER HANS PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94
Abstract: The present invention relates to a method of screening for a therapeutically useful compound which comprises testing an LC132 receptor agonist in a screening assay for psychiatric and/or neurological disorders. More particularly, the screening method is based on contacting an LC132 receptor with an agent suspected of being an agonist of the LC132 receptor function, followed by the detection of the binding and/or the agonist activity of the compound and then testing of an agent with LC132 agonist activity in an antiepileptic, anticonvulsant or anxiolytic screening assay.
-
公开(公告)号:HU9701032D0
公开(公告)日:1997-07-28
申请号:HU9701032
申请日:1997-06-11
Applicant: HOFFMANN LA ROCHE
Inventor: CIVELLI OLIVIER , MARTIN JAMES RICHARD , MONSMA FREDERICK , MOREAU JEAN-LUC , NOTHACKER HANS-PETER , REINSCHEID RAINER
IPC: G01N33/53 , A61K38/00 , A61K38/10 , A61P25/08 , A61P25/20 , A61P25/26 , G01N33/15 , G01N33/566 , G01N33/94
Abstract: The present invention relates to a method of screening for a therapeutically useful compound which comprises testing an LC132 receptor agonist in a screening assay for psychiatric and/or neurological disorders. More particularly, the screening method is based on contacting an LC132 receptor with an agent suspected of being an agonist of the LC132 receptor function, followed by the detection of the binding and/or the agonist activity of the compound and then testing of an agent with LC132 agonist activity in an antiepileptic, anticonvulsant or anxiolytic screening assay.
-
-
-
-
-
-
-
-